Globus Medical Inc. (GMED)
NYSE: GMED
· Real-Time Price · USD
58.43
0.24 (0.41%)
At close: Jun 26, 2025, 11:01 AM
Globus Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Emerging Technology Revenue | 154M | 120.22M | 96.14M | 81.32M | 40.6M | 46.99M |
| Emerging Technology Revenue Growth | +28.11% | +25.04% | +18.22% | +100.32% | -13.61% | n/a |
| Spine Revenue | 2.37B | 1.45B | 926.7M | 876.78M | 748.45M | 738.38M |
| Spine Revenue Growth | +63.32% | +56.28% | +5.69% | +17.15% | +1.36% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Non Us Revenue | 519.29M | 288.71M | 150.9M | 138.53M | 124.59M | 137.69M |
| Non Us Revenue Growth | +79.86% | +91.32% | +8.93% | +11.19% | -9.51% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 242.8M | 253.48M | 240.74M | 238.12M | 248.71M | 244.72M | 156.21M | 120.07M | 122.42M | 118.08M | 106.58M | 106.72M | 100.75M | 106.56M | 96.44M | 107.25M | 97.89M | 92.05M | 89.15M | 80.02M | 93.54M | 92.14M | 88.45M | 88.38M | 85.78M | 83.64M | 75.13M | 77.13M | 75.69M | 72.96M | 63.36M | 64.44M | 67.06M | 60.84M | 54.21M | 52.41M | 54.57M | 53.39M | 53.83M | 54.51M | 52.29M |
| Selling, General, and Administrative Revenue Growth | -4.21% | +5.29% | +1.10% | -4.26% | +1.63% | +56.66% | +30.10% | -1.92% | +3.68% | +10.79% | -0.13% | +5.93% | -5.45% | +10.49% | -10.08% | +9.56% | +6.35% | +3.25% | +11.41% | -14.45% | +1.52% | +4.16% | +0.09% | +3.03% | +2.56% | +11.33% | -2.59% | +1.89% | +3.75% | +15.14% | -1.67% | -3.91% | +10.22% | +12.23% | +3.43% | -3.96% | +2.21% | -0.82% | -1.24% | +4.24% | n/a |
| Research and Development Revenue | 33.06M | 33.41M | 35.38M | 37.7M | 44.67M | 52.25M | 29.33M | 21.35M | 21.08M | 19.51M | 18.7M | 17.39M | 17.41M | 51.02M | 15.85M | 15.55M | 14.92M | 15.24M | 14.42M | 39.45M | 15.4M | 15.5M | 14.51M | 15.75M | 14.32M | 13.76M | 15.53M | 13.52M | 12.69M | 11.41M | 10.89M | 10.71M | 10.67M | 13.64M | 10.27M | 11.25M | 10.2M | 9.84M | 9.41M | 9.08M | 8.66M |
| Research and Development Revenue Growth | -1.04% | -5.57% | -6.15% | -15.60% | -14.52% | +78.16% | +37.39% | +1.26% | +8.07% | +4.31% | +7.51% | -0.10% | -65.87% | +221.84% | +1.97% | +4.17% | -2.08% | +5.69% | -63.45% | +156.17% | -0.61% | +6.81% | -7.86% | +9.93% | +4.11% | -11.39% | +14.82% | +6.57% | +11.18% | +4.83% | +1.62% | +0.44% | -21.82% | +32.91% | -8.76% | +10.31% | +3.69% | +4.54% | +3.61% | +4.91% | n/a |